RECRUITING

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

Talk to us

Conditions

Skin LesionSkin CancerSkin MelanomaTumor Skin

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This protocol will take measurements of a variety of tumors involving the skin in order to assess changes in tumor oxygen from hyperoxygenation therapy and standard cancer-directed treatments, to demonstrate the clinical feasibility of using in vivo Electron Paramagnetic Resonance (EPR) Oximetry to obtain clinically useful measurements of tumor oxygen levels from cancer patients.

Official Title

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

Quick Facts

Study Start:2019-10-17
Study Completion:2024-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03716193

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pathology-proven (histology or cytology) malignancy of any histology and site of origin
  2. * Visible tumor (primary or metastasis) involving the skin of at least 6 mm in diameter
  3. * Negative serum or urine pregnancy test within 72 hours prior to registration for women of childbearing potential
  1. * Implanted electric, magnetic or mechanically activated devices like a pacemaker, defibrillator, nerve stimulator, cochlear implant or portable infusion pump. Also individuals who have any non-MRI compatible implants
  2. * Individuals who have a ferromagnetic foreign body located in their body
  3. * Prior adverse reaction to a charcoal product (e.g., a local hypersensitive response from a black tattoo or from ingestion of activated charcoal)
  4. * Prior adverse reaction to gum Arabic, which is an ingredient in the India ink
  5. * Prior allergic reaction to medical adhesives
  6. * Psychiatric illness/social situations that would limit compliance with study requirements
  7. * Pregnant or lactating women. There is no known harm to the woman or her fetus from participating; this is precautionary only

Contacts and Locations

Study Contact

Todd Tenenholz, MD
CONTACT
304-293-7227
todd.tenenholz@hsc.wvu.edu

Principal Investigator

Todd Tenenholz, MD
PRINCIPAL_INVESTIGATOR
West Virginia University

Study Locations (Sites)

Todd Tenenholz
Morgantown, West Virginia, 26506
United States

Collaborators and Investigators

Sponsor: West Virginia University

  • Todd Tenenholz, MD, PRINCIPAL_INVESTIGATOR, West Virginia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-10-17
Study Completion Date2024-07

Study Record Updates

Study Start Date2019-10-17
Study Completion Date2024-07

Terms related to this study

Additional Relevant MeSH Terms

  • Skin Lesion
  • Skin Cancer
  • Skin Melanoma
  • Tumor Skin